Aurobindo Pharma shares are in focus after USFDA approval for Perampanel tablets, raising investor interest and market potential.
Read MoreAurobindo Pharma shares are in focus after USFDA approval for Perampanel tablets, raising investor interest and market potential.
Read MoreEye implant for inflammation offers a promising treatment for chronic eye conditions. Discover the latest insights from the upcoming presentation.
Read More
Drug price gaps are highlighted by Karnataka, revealing significant issues in the pharma sector.
Read More
Fexuclu launch in Indonesia marks a significant expansion of Daewoong in Southeast Asia.
Read More
Aurobindo Pharma inhaler approval brings a proven safe solution for asthma patients seeking effective treatment options.
Read More